Indacaterol is an ultra-long-acting beta2-adrenergic agonist bronchodilator developed as a pharmaceutical active ingredient. It is designed for once-daily administration in the management of chronic obstructive pulmonary disease.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 312753-06-3
Indacaterol maleate
pharmaceutical raw material
Hygromycin B
pharmaceutical raw material
Potassium N-sulfoglucosamine
pharmaceutical raw material
Estradiol cypionate
pharmaceutical raw material
Regadenoson
pharmaceutical raw material
5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one
QZZUEBNBZAPZLX-QFIPXVFZSA-N
CCC1=C(C=C2CC(CC2=C1)NC[C@@H](C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC